NEW! If you don't understand one of the words in this article,
just double-click it.
A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature
doesn't work in your browser, you can enter the word below:
Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.
July 20, 2007
FDA Declines Serostim Approval for Lipo
The Food and Drug Administration (FDA) declined this week to approveSerostim for the treatment of HIV-associated adipose redistribution syndrome (HARS)—the accumulation of fat associated with lipodystrophy. The drug, which has been in use since 1996 to treat AIDS-related wasting syndrome, may not be marketed for lipo. A spokesperson from Serostim-maker EMD Serono said that the company “remains committed to continuing our discussions with the FDA to obtain approval of Serostim for the treatment of HARS.” The FDA is expected to explain its decision next week.
